The increasing use of psychotropic medicaThe increasing use of psychotropic medication to treat child and adolescent disorders tion to treat child and adolescent disorders is causing concern in the community. This is causing concern in the community. This particularly applies to the use of stimulants particularly applies to the use of stimulants such as amphetamines and methylphenisuch as amphetamines and methylphenidate. Is the prescription of stimulants redate. Is the prescription of stimulants restricted to conditions for which they are stricted to conditions for which they are an effective treatment? Is the medical proan effective treatment? Is the medical profession placing too much emphasis on the fession placing too much emphasis on the use of medication to treat childhood mental use of medication to treat childhood mental health problems and failing to utilise effechealth problems and failing to utilise effective non-drug treatments? Are worries tive non-drug treatments? Are worries about overuse of stimulants the reaction about overuse of stimulants the reaction of an ill-informed public? of an ill-informed public?
PHARMACO-EPIDEMIOLOGY PHARMACO-EPIDEMIOLOGY OF STIMULANTS OF STIMULANTS
Reliable information on the pharmacoReliable information on the pharmacoepidemiology of stimulants is scarce, partiepidemiology of stimulants is scarce, particularly in relation to Europe. The overall cularly in relation to Europe. The overall prevalence of stimulant use in children has prevalence of stimulant use in children has been estimated as 1-6% in the USA (Jensen been estimated as 1-6% in the USA (Jensen (Kewley, 1998) . There is 0.03% in Britain (Kewley, 1998). There is good evidence that treatment with stimugood evidence that treatment with stimulants has been increasing in the USA, lants has been increasing in the USA, Canada and Australia, although there are Canada and Australia, although there are large variations between countries and large variations between countries and between regions within countries (Jensen between regions within countries (Jensen et al et al, 1999).
, 1999). The surveys that have examined comThe surveys that have examined community samples of young people with munity samples of young people with attention-deficit hyperactivity disorder attention-deficit hyperactivity disorder (ADHD) and medication use are sum-(ADHD) and medication use are summarised in Table 1 . Even in countries with marised in Table 1 . Even in countries with higher prescription rates, such as the USA higher prescription rates, such as the USA and Australia, many children with ADHD and Australia, many children with ADHD do not receive medication. do not receive medication.
Children without ADHD treated Children without ADHD treated with stimulants with stimulants
The surveys listed in Table 1 also show that  The surveys listed in Table 1 also show that a substantial number of children who did a substantial number of children who did not meet criteria for ADHD were treated not meet criteria for ADHD were treated with stimulants. Although the population with stimulants. Although the population percentages were small (0.5-4%), they percentages were small (0.5-4%), they represented between 18% and 72% of all represented between 18% and 72% of all young people being prescribed these drugs. young people being prescribed these drugs. Not surprisingly, the diagnostic criteria Not surprisingly, the diagnostic criteria used have a large impact on the estimates of used have a large impact on the estimates of the number of children with and without the number of children with and without ADHD who are treated. For example, if ADHD who are treated. For example, if instead of any subtype of ADHD only the instead of any subtype of ADHD only the combined subtype was used to identify combined subtype was used to identify those with ADHD in the Australian study those with ADHD in the Australian study (this information is not available for the (this information is not available for the other reports), the proportion of children other reports), the proportion of children not meeting criteria for ADHD but renot meeting criteria for ADHD but receiving stimulants would increase from ceiving stimulants would increase from 23% of all those receiving stimulants 23% of all those receiving stimulants (14 879 children aged 6-17 years (14 879 children aged 6-17 years Australia-wide) to 56% (35 032). The Australia-wide) to 56% (35 032). The combined subtype requires the presence of combined subtype requires the presence of symptoms of inattention, impulsivity and symptoms of inattention, impulsivity and overactivity. The two other subtypes are overactivity. The two other subtypes are new diagnoses introduced in DSM-IV: the new diagnoses introduced in DSM-IV: the inattentive form needs symptoms of inattentive form needs symptoms of inattention only, and the impulsiveinattention only, and the impulsivehyperactive subtype requires symptoms of hyperactive subtype requires symptoms of impulsivity and overactivity only. The comimpulsivity and overactivity only. The combined subtype is similar (but not identical) bined subtype is similar (but not identical) to ADHD in DSM-III-R and to hyperto ADHD in DSM-III-R and to hyperkinetic disorder in ICD-10 (World Health kinetic disorder in ICD-10 (World Health Organization, 1992), corresponds to the Organization, 1992), corresponds to the traditional construct of ADHD, and is the traditional construct of ADHD, and is the better researched and validated form of better researched and validated form of the condition (almost all treatment studies the condition (almost all treatment studies involve the participation of patients with involve the participation of patients with this syndrome). Therefore, the most approthis syndrome). Therefore, the most appropriate rate to consider when comparing priate rate to consider when comparing these studies may be that observed when these studies may be that observed when only the combined subtype is included. only the combined subtype is included. The results thus obtained are similar across The results thus obtained are similar across the studies for which data are available: the studies for which data are available: half or more of all the children treated with half or more of all the children treated with stimulants did not meet criteria for the stimulants did not meet criteria for the combined subtype ( These conclusions may be incorrect, These conclusions may be incorrect, because instruments used in epidemiological because instruments used in epidemiological studies may underdiagnose or misdiagnose studies may underdiagnose or misdiagnose ADHD, or because a full diagnostic assess-ADHD, or because a full diagnostic assessment similar to that conducted in clinical ment similar to that conducted in clinical practice (in which other information may practice (in which other information may be considered) is not possible. Further, be considered) is not possible. Further, there are several reasons why children withthere are several reasons why children without ADHD may be prescribed stimulants. out ADHD may be prescribed stimulants. First, it is possible that they have subFirst, it is possible that they have subsyndromal forms of the condition that syndromal forms of the condition that nevertheless cause impairment. Second, nevertheless cause impairment. Second, the troublesome behaviour of some chilthe troublesome behaviour of some children may be misdiagnosed (e.g. by mistakdren may be misdiagnosed (e.g. by mistaking non-compliance, learning or conduct ing non-compliance, learning or conduct problems for ADHD). Third, clinicians in problems for ADHD). Third, clinicians in ordinary practice may prescribe stimulant ordinary practice may prescribe stimulant drugs not only for ADHD but also for other drugs not only for ADHD but also for other emotional and behavioural problems in an emotional and behavioural problems in an attempt to manage difficult children or to attempt to manage difficult children or to enhance school performance. Finally -and enhance school performance. Finally -and most importantly -it may be that stimumost importantly -it may be that stimulant treatment had reduced the symptoms lant treatment had reduced the symptoms experienced by children with ADHD; experienced by children with ADHD; hence, they would not meet criteria for hence, they would not meet criteria for diagnosis at the time of interview in diagnosis at the time of interview in epidemiological studies. epidemiological studies.
Regrettably, there is limited evidence to Regrettably, there is limited evidence to support or disprove these explanations, and support or disprove these explanations, and more research is required. However, a more research is required. However, a multiple-wave study showed that 56% of multiple-wave study showed that 56% of the treated children without ADHD began the treated children without ADHD began receiving medication after the first interreceiving medication after the first interview (Angold view (Angold et al et al, 2000). These children , 2000). These children had not met criteria for ADHD prior to had not met criteria for ADHD prior to stimulant treatment. At the assessment stimulant treatment. At the assessment before that in which they began stimulant before that in which they began stimulant 2 8 4 2 8 4
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
( 2 0 0 3 ) , 1 8 2 , 2 8 4^2 8 6 ( 2 0 0 3 ) , 1 8 2 , 2 8 4^2 8 6
E D I T O R I A L E D I T O R I A L
Are psychostimulant drugs being used Are psychostimulant drugs being used appropriately to treat child and adolescent appropriately to treat child and adolescent disorders? disorders?
JOSEPH M. REY and MICHAEL G. SAW YER JOSEPH M. REY and MICHAEL G. SAW YER treatment, 71% had no parent-reported treatment, 71% had no parent-reported ADHD symptoms, 27% had just one and ADHD symptoms, 27% had just one and 2% had three. Their counts of ADHD 2% had three. Their counts of ADHD symptoms the following year, while taking symptoms the following year, while taking stimulant medication, were as follows: stimulant medication, were as follows: 56% had no symptoms, 2% had one, 2% 56% had no symptoms, 2% had one, 2% had two, 38% had three and 2% had had two, 38% had three and 2% had eleven. The authors concluded that low eleven. The authors concluded that low symptom counts in those started on stimusymptom counts in those started on stimulants during the course of the study could lants during the course of the study could not be accounted for by the curative effect not be accounted for by the curative effect of the drug. of the drug.
CLINICAL PR ACTICE CLINICAL PRACTICE GUIDELINES GUIDELINES
Overprescription, underprescription and Overprescription, underprescription and inappropriate prescription of stimulants coinappropriate prescription of stimulants coexist and variations appear to be specific to exist and variations appear to be specific to country, region and provider (Jensen country, region and provider ( This may be more of a interpretation. This may be more of a problem when clinicians are not skilled in problem when clinicians are not skilled in psychiatric diagnosis, particularly in a conpsychiatric diagnosis, particularly in a condition such as ADHD that relies on reports dition such as ADHD that relies on reports from informants (e.g. parents) rather than from informants (e.g. parents) rather than on direct observation or examination of on direct observation or examination of children by medical practitioners. children by medical practitioners.
In contrast, the guidelines of the In contrast, the guidelines of the American Academy of Pediatrics state that American Academy of Pediatrics state that once diagnosis is made (any subtype), once diagnosis is made (any subtype), clinicians should recommend stimulant clinicians should recommend stimulant medication and/or behaviour therapy medication and/or behaviour therapy (American Academy of Pediatrics, 2001). (American Academy of Pediatrics, 2001). If this were followed, up to 17% of all boys If this were followed, up to 17% of all boys aged 6-12 years might warrant stimulant aged 6-12 years might warrant stimulant 
CONCLUSIONS CONCLUSIONS
Given the limited data available, partiGiven the limited data available, particularly from the UK, no general conclusions cularly from the UK, no general conclusions can be made. Although there is much evican be made. Although there is much evidence for the effectiveness of stimulants dence for the effectiveness of stimulants for the combined subtype of ADHD, confor the combined subtype of ADHD, concern may be justified about the number of cern may be justified about the number of children without ADHD who are being prechildren without ADHD who are being prescribed stimulants in the USA and Austrascribed stimulants in the USA and Australia -mainly because ADHD is a chronic lia -mainly because ADHD is a chronic condition and treatment usually lasts years condition and treatment usually lasts years not weeks. Guidelines for the treatment of not weeks. Guidelines for the treatment of ADHD are multiplying but they are in-ADHD are multiplying but they are inconsistent and leave too much scope for consistent and leave too much scope for interpretation. It is important to discuss interpretation. It is important to discuss where we should draw the line for stimuwhere we should draw the line for stimulant treatment: all those who meet criteria lant treatment: all those who meet criteria for severe hyperkinetic disorder? At any for severe hyperkinetic disorder? At any form of ADHD? Should those who 'almost' form of ADHD? Should those who 'almost' meet criteria be treated also? European meet criteria be treated also? European countries, where rates of stimulant precountries, where rates of stimulant prescription are lower, can learn from the scription are lower, can learn from the American and Australian experiences. A American and Australian experiences. A first step would be to monitor prescription first step would be to monitor prescription trends. trends. Improving accuracy and effectiveness in Improving accuracy and effectiveness in the treatment of ADHD as well as achievthe treatment of ADHD as well as achieving the right balance between pharmacoing the right balance between pharmacological and psychological interventions logical and psychological interventions may be a 'litmus test'. If the medical promay be a 'litmus test'. If the medical profession, the pharmaceutical industry and fession, the pharmaceutical industry and policy-makers fail in this, the backlashpolicy-makers fail in this, the backlashwhich has already started -may hinder which has already started -may hinder progress in this area, and children will be progress in this area, and children will be the losers. the losers.
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